Zhitong Finance App News, Vision Life (300642.SZ) issued an announcement. The company recently obtained two medical device registration certificates issued by the Shanghai Drug Administration. The product names are: sugar antigen 125, human epididymal protein 4 determination kit (flow fluorescence luminescence method), and 15 autoimmune myositis antibody spectrum IgG test kit (flow fluorescence luminescence method).

The acquisition of the above medical device registration certificate has enriched the company's product line layout in the flow fluorescence technology platform, further consolidated the company's dominant position in the domestic field of flow fluorescence, enhanced the company's overall competitiveness in the field of in vitro diagnosis, and enhanced the company's overall brand influence and market expansion capabilities.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.